HTG Molecular Diagnostics, INC
SEC CIK 1169987 · HTGM · last insider filing 2023-06-09
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Lubniewski John L | Director · SVP, Chief Business Officer | filed 2015–2022 |
| Hardison DON M | Director | filed 2016–2022 |
| Griffin Michelle Renee | Director | filed 2018–2022 |
| Kiritsy Christopher P | Director | filed 2022–2022 |
| Hanham ANN | Director | filed 2016–2022 |
| Mccracken Lee R. | Director | filed 2015–2022 |
| Dubensky Thomas W. | Director | filed 2022–2022 |
| Lafrance James T | Director | filed 2015–2021 |
| George Harry A. | Director | filed 2015–2021 |
| Johnson TIM B | Director · President & CEO | filed 2015–2021 |
| Shuster Lewis | Director | filed 2015–2017 |
| Grimm Donald W | Director | filed 2015–2015 |
| George Simeon | Director | filed 2015–2015 |
| Bisgaard Peter | Director | filed 2015–2015 |
| Hoult Mary | Director | filed 2015–2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Barat Stephen | Senior VP of Therapeutics | filed 2023–2023 |
| Mcmeans Shaun D | VP, Finance & Admin. & CFO | filed 2015–2022 |
| Godlewski Laura Lee | VP of Accounting and Reporting | filed 2019–2022 |
| Lawson Byron | SVP/Chief Commercial Officer | filed 2020–2022 |
| Roche Patrick C. | SVP Research & Development | filed 2015–2018 |
| Gordon Debra A | V.P. and Chief Legal Counsel | filed 2015–2018 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.